Pellegrino Joseph P JR 4

What Happened

• Joseph P. Pellegrino Jr., a director of Lemaitre Vascular (LMAT), was credited with a total of 16.2 shares on March 26, 2026. These were reported as derivative acquisitions (code A) at $0.00 each — dividend equivalent rights that accrued on previously granted restricted stock units (RSUs) and performance share units (PSUs). No cash purchase or open-market trade occurred.

Key Details

• Transaction date: 2026-03-26; Form 4 filed: 2026-03-30 (filed within the usual 2-business-day Form 4 deadline for a 3/26 transaction).
• Shares acquired: seven separate accruals totaling 16.2 shares; price reported: $0.00 per share; reported value: $0.
• Nature of award: dividend-equivalent rights that are the economic equivalent of one share each and vest proportionately with the underlying RSU/PSU awards.
• Grants tied to underlying awards dated: 12/12/2022, 12/8/2023, 12/6/2024, and 12/10/2025 (per footnotes F1–F7).
• Shares owned after the transaction: not specified in the provided excerpt of the filing.

Context

• These are not purchases or sales — they are accruals of dividend-equivalent units associated with existing equity awards. Such credits typically increase the insider’s eventual share delivery when the underlying RSUs/PSUs vest and do not by themselves indicate a buy/sell signal.